Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hosoda, Kiminori"" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł:
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study).
Autorzy:
Tamanaha T; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan. .; Department of Advanced Cardiovascular Prevention and Epidemiology, Tohoku University Graduate School of Medicine and Tohoku University Hospital, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan. .
Makino H; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Son C; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Koezuka R; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.; Department of Advanced Cardiovascular Prevention and Epidemiology, Tohoku University Graduate School of Medicine and Tohoku University Hospital, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Tochiya M; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.; Department of Advanced Cardiovascular Prevention and Epidemiology, Tohoku University Graduate School of Medicine and Tohoku University Hospital, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Omura-Ohata Y; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.; Department of Advanced Cardiovascular Prevention and Epidemiology, Tohoku University Graduate School of Medicine and Tohoku University Hospital, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Takekawa T; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Matsubara M; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Noguchi M; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Tomita T; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Honda-Kohmo K; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Matsuo M; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Tateishi E; Department of Radiology, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, Japan.
Fukuda T; Department of Radiology, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, Japan.
Miyamoto Y; Open Innovation Center, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, Japan.; Department of Advanced Cardiovascular Prevention and Epidemiology, Tohoku University Graduate School of Medicine and Tohoku University Hospital, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Yasuda S; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine and Tohoku University Hospital, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.; Department of Advanced Cardiovascular Prevention and Epidemiology, Tohoku University Graduate School of Medicine and Tohoku University Hospital, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, Japan.
Hosoda K; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Pokaż więcej
Źródło:
Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2024 Apr 04. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study.
Autorzy:
Sakane N; Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Hirota Y; Division of Diabetes and Endocrinology, The Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan.
Yamamoto A; Division of Diabetes and Endocrinology, The Department of Internal Medicine, Kobe University Graduate School of Medicine, Hyogo, Japan.
Miura J; Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Takaike H; Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Hoshina S; Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Toyoda M; Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
Saito N; Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
Hosoda K; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Osaka, Japan.
Matsubara M; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Osaka, Japan.; Department of General Medicine, Nara Medical University, Nara, Japan.
Tone A; Department of Internal Medicine, Okayama Saiseikai General Hospital, Okayama, Japan.
Kawashima S; Kanda Naika Clinic, Osaka, Japan.
Sawaki H; Sawaki Internal Medicine and Diabetes Clinic, Osaka, Japan.
Matsuda T; Matsuda Diabetes Clinic, Kobe, Japan.
Domichi M; Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Suganuma A; Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Sakane S; Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Murata T; Department of Clinical Nutrition, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.; Diabetes Center, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2023 Apr; Vol. 14 (4), pp. 582-590. Date of Electronic Publication: 2023 Feb 14.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 1*/complications
Diabetes Mellitus, Type 2*/complications
Humans ; Adult ; Female ; Middle Aged ; Aged ; Glycated Hemoglobin ; Blood Glucose/analysis ; Maillard Reaction ; Blood Glucose Self-Monitoring ; Japan/epidemiology ; Cross-Sectional Studies ; Hemoglobins/analysis
Czasopismo naukowe
Tytuł:
First Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy Showing Refractory Ventricular Tachycardia Induced by Thyroid Storm due to Graves' Disease.
Autorzy:
Matsubara M; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka 564-8565, Japan.
Tanaka T; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka 564-8565, Japan.
Wakamiya A; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka 564-8565, Japan.
Tamanaha T; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka 564-8565, Japan.
Makino H; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka 564-8565, Japan.
Tanei T; Department of Breast and Endocrine Surgery, Osaka University Graduate School of Medicine, 2-2-E10 Yamadaoka, Suita, Osaka 565-0871, Japan.
Aiba T; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka 564-8565, Japan.
Kusano K; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka 564-8565, Japan.
Hosoda K; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka 564-8565, Japan.
Pokaż więcej
Źródło:
Case reports in endocrinology [Case Rep Endocrinol] 2022 Jun 23; Vol. 2022, pp. 6078148. Date of Electronic Publication: 2022 Jun 23 (Print Publication: 2022).
Typ publikacji:
Case Reports
Raport
Tytuł:
A Prospective Longitudinal Study on the Relationship Between Glucose Fluctuation and Cognitive Function in Type 2 Diabetes: PROPOSAL Study Protocol.
Autorzy:
Matsubara M; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Makino H; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. .
Washida K; Department of Neurology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Matsuo M; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Koezuka R; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Ohata Y; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Tamanaha T; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Honda-Kohmo K; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Noguchi M; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Tomita T; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Son C; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Nakai M; Center for Cerebral and Cardiovascular Disease Information, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Nishimura K; Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Miyamoto Y; Center for Cerebral and Cardiovascular Disease Information, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Ihara M; Department of Neurology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Hosoda K; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Pokaż więcej
Źródło:
Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2020 Nov; Vol. 11 (11), pp. 2729-2737. Date of Electronic Publication: 2020 Sep 05.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Effect of tofogliflozin on cardiac and vascular endothelial function in patients with type 2 diabetes and heart diseases: A pilot study.
Autorzy:
Tochiya M; Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Makino H; Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Tamanaha T; Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Matsuo M; Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Hishida A; Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Koezuka R; Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Ohata Y; Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Tomita T; Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Son C; Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Miyamoto Y; Division of Preventive Cardiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Yasuda S; Division of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Hosoda K; Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Pokaż więcej
Źródło:
Journal of diabetes investigation [J Diabetes Investig] 2020 Mar; Vol. 11 (2), pp. 400-404. Date of Electronic Publication: 2019 Aug 14.
Typ publikacji:
Journal Article
MeSH Terms:
Benzhydryl Compounds/*administration & dosage
Diabetes Mellitus, Type 2/*drug therapy
Endothelial Cells/*drug effects
Glucosides/*administration & dosage
Heart Diseases/*drug therapy
Sodium-Glucose Transporter 2 Inhibitors/*administration & dosage
Aged ; Female ; Humans ; Male ; Middle Aged ; Pilot Projects ; Treatment Outcome ; Ventricular Function, Left
Czasopismo naukowe
Tytuł:
Rationale, Design, and Methods of the Study of Comparison of Canagliflozin vs. Teneligliptin Against Basic Metabolic Risks in Patients with Type 2 Diabetes Mellitus (CANTABILE study): Protocol for a Randomized, Parallel-Group Comparison Trial.
Autorzy:
Son C; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. .
Kasahara M; Institute for Clinical and Translational Science, Nara Medical University Hospital, Kashihara, Nara, Japan.
Tanaka T; Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Satoh-Asahara N; Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Kusakabe T; Department of Endocrinology, Metabolism, and Hypertension Research, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Nishimura K; Department of Preventive Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Miyamoto Y; Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Kasama S; Institute for Clinical and Translational Science, Nara Medical University Hospital, Kashihara, Nara, Japan.
Hosoda K; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Pokaż więcej
Źródło:
Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2020 Jan; Vol. 11 (1), pp. 347-358. Date of Electronic Publication: 2019 Nov 01.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Efficacy of visceral fat estimation by dual bioelectrical impedance analysis in detecting cardiovascular risk factors in patients with type 2 diabetes.
Autorzy:
Omura-Ohata Y; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 kishibeshin-machi, Suita, Osaka, 564-8565, Japan.
Son C; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 kishibeshin-machi, Suita, Osaka, 564-8565, Japan. .
Makino H; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 kishibeshin-machi, Suita, Osaka, 564-8565, Japan.
Koezuka R; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 kishibeshin-machi, Suita, Osaka, 564-8565, Japan.
Tochiya M; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 kishibeshin-machi, Suita, Osaka, 564-8565, Japan.
Tamanaha T; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 kishibeshin-machi, Suita, Osaka, 564-8565, Japan.
Kishimoto I; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 kishibeshin-machi, Suita, Osaka, 564-8565, Japan.
Hosoda K; Division of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, 6-1 kishibeshin-machi, Suita, Osaka, 564-8565, Japan.
Pokaż więcej
Źródło:
Cardiovascular diabetology [Cardiovasc Diabetol] 2019 Oct 22; Vol. 18 (1), pp. 137. Date of Electronic Publication: 2019 Oct 22.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adiposity*
Cardiovascular Diseases/*epidemiology
Diabetes Mellitus, Type 2/*epidemiology
Intra-Abdominal Fat/*physiopathology
Obesity/*diagnosis
Aged ; Biomarkers/blood ; Cardiovascular Diseases/diagnosis ; Comorbidity ; Diabetes Mellitus, Type 2/diagnosis ; Dyslipidemias/epidemiology ; Electric Impedance ; Female ; Humans ; Hypertension/epidemiology ; Intra-Abdominal Fat/diagnostic imaging ; Japan/epidemiology ; Male ; Middle Aged ; Natriuretic Peptide, Brain/blood ; Obesity/epidemiology ; Obesity/physiopathology ; Predictive Value of Tests ; Prevalence ; Reproducibility of Results ; Risk Factors ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł:
Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study.
Autorzy:
Nishimura A; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Harashima SI; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan. .; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan. .
Hosoda K; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Division of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Osaka, Japan.
Inagaki N; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Pokaż więcej
Źródło:
Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2018 Aug; Vol. 9 (4), pp. 1501-1510. Date of Electronic Publication: 2018 Jun 12.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Effectiveness of nationwide screening and lifestyle intervention for abdominal obesity and cardiometabolic risks in Japan: The metabolic syndrome and comprehensive lifestyle intervention study on nationwide database in Japan (MetS ACTION-J study).
Autorzy:
Nakao YM; Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Miyamoto Y; Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Ueshima K; Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Kyoto, Japan.
Nakao K; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Nakai M; Department of Statistics and Data Analysis, Center for Cerebral and Cardiovascular Disease Information, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Nishimura K; Department of Statistics and Data Analysis, Center for Cerebral and Cardiovascular Disease Information, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Yasuno S; Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Kyoto, Japan.
Hosoda K; Department of Endocrinology and Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Ogawa Y; Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Itoh H; Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Ogawa H; National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Kangawa K; National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Nakao K; Medical Innovation Center, Kyoto University School of Medicine, Kyoto, Kyoto, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Jan 09; Vol. 13 (1), pp. e0190862. Date of Electronic Publication: 2018 Jan 09 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Life Style*
Metabolic Syndrome/*diagnosis
Obesity/*diagnosis
Adult ; Aged ; Humans ; Japan ; Metabolic Syndrome/physiopathology ; Metabolic Syndrome/prevention & control ; Middle Aged ; Obesity/physiopathology ; Obesity/prevention & control ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł:
A Large Difference in Dose Timing of Basal Insulin Introduces Risk of Hypoglycemia and Overweight: A Cross-Sectional Study.
Autorzy:
Nishimura A; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Harashima SI; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan. .
Fukushige H; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Foundation of Nursing, Kobe City College of Nursing, Kobe, Japan.
Wang Y; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Liu Y; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hosoda K; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Division of Endocrinology and Metabolism, Department of Lifestyle-Related Diseases, National Cerebral and Cardiovascular Center, Suita, Japan.
Inagaki N; Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Pokaż więcej
Źródło:
Diabetes therapy : research, treatment and education of diabetes and related disorders [Diabetes Ther] 2017 Apr; Vol. 8 (2), pp. 385-399. Date of Electronic Publication: 2017 Feb 24.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Establishment of Leptin-Responsive Cell Lines from Adult Mouse Hypothalamus.
Autorzy:
Iwakura H; Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Dote K; Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Bando M; Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Koyama H; Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hosoda K; Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Kangawa K; Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.; National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.
Nakao K; Medical Innovation Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 Feb 05; Vol. 11 (2), pp. e0148639. Date of Electronic Publication: 2016 Feb 05 (Print Publication: 2016).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Resistance/*drug effects
Hypothalamus/*metabolism
Leptin/*pharmacology
Animals ; Cell Line ; Drug Resistance/genetics ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Hypothalamus/cytology ; Insulin/metabolism ; Mice ; Mice, Transgenic ; Oncogene Proteins v-fos/metabolism ; Phosphorylation/drug effects ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/metabolism ; Tamoxifen/pharmacology
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies